Waiting to get rich from biotech? Don’t hold your breath
Investing in biotechs and other healthcare start-ups has long been notoriously high risk, high reward. The global Australian success stories such as CSL and Cochlear and relative newcomers, including Telix Pharmaceuticals and Neuren Pharmaceuticals, are …